Black Diamond Therapeutics, Inc.BDTXNASDAQ
Loading
Year-over-year book value per share growth
Latest
-11.73%
↓ 136% vs avg
Percentile
P39
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
32.68%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -11.73% |
| Q3 2025 | -4.62% |
| Q2 2025 | -6.52% |
| Q1 2025 | 69.75% |
| Q4 2024 | -14.67% |
| Q3 2024 | -14.35% |
| Q2 2024 | -0.02% |
| Q1 2024 | -18.17% |
| Q4 2023 | -6.69% |
| Q3 2023 | 17.13% |
| Q2 2023 | -16.36% |
| Q1 2023 | -15.35% |
| Q4 2022 | -13.27% |
| Q3 2022 | -12.69% |
| Q2 2022 | -11.75% |
| Q1 2022 | -12.01% |
| Q4 2021 | -10.55% |
| Q3 2021 | -12.86% |
| Q2 2021 | -10.74% |
| Q1 2021 | -9.03% |
| Q4 2020 | -6.23% |
| Q3 2020 | -4.64% |
| Q2 2020 | -36.26% |
| Q1 2020 | 1137.47% |
| Q4 2019 | -126.49% |
| Q3 2019 | 96.52% |
| Q2 2019 | 0.00% |
| Q1 2019 | 100.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |